EXHIBIT 99.2
Q1 2006 Preliminary Consolidated Financial Results
(in millions, except per share amounts)
Range for Q1 2006 | ||||||||
Revenue | $ | 338.0 | $ | 339.0 | ||||
Adjusted EBITDA per diluted share | $ | 0.18 | $ | 0.18 | ||||
Reconciliation of Adjusted EBITDA per diluted share to Net Income per diluted share: | ||||||||
Interest expense | $ | — | $ | — | ||||
Depreciation and amortization | 0.06 | 0.06 | ||||||
Non-cash stock-based compensation | 0.04 | 0.04 | ||||||
Non-cash advertising | 0.01 | 0.01 | ||||||
Income tax provision | 0.02 | 0.01 | ||||||
Minority interest in WebMD Health Corp. | — | — | ||||||
Net income per diluted share | $ | 0.05 | $ | 0.06 | ||||
2006 Consolidated Financial Guidance Summary
(in millions, except per share amounts)
Range for FY 2006 | ||||||||
Revenue | $ | 1,380.0 | $ | 1,430.0 | ||||
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) | $ | 225.0 | $ | 255.0 | ||||
Reconciliation of Adjusted EBITDA per diluted share to Net Income per diluted share: | ||||||||
Interest expense | $ | 3.0 | $ | 4.0 | ||||
Depreciation and amortization | 75.5 | 80.1 | ||||||
Non-cash stock-based compensation | 48.0 | 50.0 | ||||||
Non-cash advertising | 7.3 | 7.5 | ||||||
Income tax provision | 21.0 | 22.6 | ||||||
Legal expense | 0.5 | 0.5 | ||||||
Minority interest in WebMD Health Corp. | (0.3 | ) | 0.3 | |||||
Net income | $ | 70.0 | $ | 90.0 | ||||
Adjusted EBITDA per diluted share | $ | 0.75 | $ | 0.85 | ||||
Net income per diluted share | $ | 0.23 | $ | 0.30 |
Notes:
* | The 2006 guidance includes estimated expenses for Q1 2006, but does not reflect any projected expenses related to the on-going Department of Justice Investigation. | ||
* | Adjusted EBITDA per diluted share and net income per diluted share are both calculated on an assumed share count of approximately 299 million. | ||
* | Non-cash stock-based compensation expense considers the January 1, 2006 adoption of SFAS 123R, “Share-Based Payment.” | ||
* | The 2006 Guidance does not include the impact of the acquisition of Summex Corp. announced by WebMD Health on Monday, April 17, 2006. |